SCHEMBL9104892

SCHEMBL9104892

Cc1ccc(C(=O)NC2(C)CC2)cc1-c1cc2cnnc(-c3ccc(F)cc3F)c2n(C)c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1310925 0.92 MAPK14 (0.85) MAPK14
SCHEMBL1311225 0.88 MAPK14 (1.00) MAPK14
SCHEMBL1310604 0.86 MAPK14 (1.00) MAPK14
SCHEMBL1312373 0.86 MAPK14 (0.79) MAPK14
SCHEMBL1311772 0.85 MAPK14 (1.00) MAPK14
SCHEMBL1310858 0.85 MAPK14 (0.80) MAPK14
SCHEMBL1311202 0.84 MAPK14 (0.79) MAPK14
SCHEMBL1312162 0.83 MAPK14 (0.77) MAPK14
SCHEMBL1311301 0.82 MAPK14 (0.75) MAPK14
SCHEMBL1311191 0.82 MAPK14 (0.75) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334674-B1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases. AMGEN INC (US) 2012-06-06 EP disclosed